From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Plant Health Care – 2022 results, is “frustrated” by the share price performance justified?

By Steve Moore | Tuesday 2 May 2023

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Provider of biological products to enhance farming, Plant Health Care (PHC) states that it “is pleased to announce its results for the year ended 31 December 2022… revenue up 40% to $11.8m… on track to deliver long-term targeted revenue, cash breakeven and profitability”. So what of a current share price of 9.5p, down 18%, despite the announcement including that already “the board is frustrated that the company's share price performance does not reflect the positive progress in the delivery of its strategy”?
You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was



H&T Group – now again a Buy

Time left: 07:28:35